Encompass Health Corp. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

1,544.60

1,477.50

1,457.70

1,455.40

1,405.00

1,351.00

1,301.20

Other Operating Income

0.00

Total Operating income

1,544.60

1,477.50

1,457.70

1,455.40

1,405.00

1,351.00

1,301.20

Raw Material Cost

1,192.80

1,177.80

1,139.20

1,136.10

1,118.20

1,087.90

1,035.10

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

801.10

784.80

767.70

762.30

756.80

732.10

700.50

Power Cost

0.00

Manufacturing Expenses

30.20

30.80

30.40

31.80

33.00

34.90

34.30

Selling and Distribution Expenses

68.40

56.10

59.40

52.30

54.50

54.00

50.50

Other Expenses

-83.13

-81.56

-79.81

-79.41

-78.98

-76.70

-73.48

Total Expenditure (Excl Depreciation)

1,261.20

1,233.90

1,198.60

1,188.40

1,172.70

1,141.90

1,085.60

Operating Profit (PBDIT) excl Other Income

283.4

243.6

259.1

267

232.3

209.1

215.6

Other Income

4.50

7.10

8.10

3.40

2.30

10.00

4.70

Operating Profit (PBDIT)

374.30

333.10

347.10

349.60

312.60

297.50

293.20

Interest

30.20

30.80

30.40

31.80

33.00

34.90

34.30

Exceptional Items

0.00

-0.20

-0.40

0.00

Gross Profit (PBDT)

351.80

299.70

318.50

319.30

286.80

263.10

266.10

Depreciation

86.40

82.40

79.90

79.20

78.00

78.40

72.90

Profit Before Tax

257.70

219.90

236.80

238.60

201.40

183.80

186.00

Tax

55.40

44.90

51.00

41.60

37.60

36.00

38.30

Provisions and contingencies

0.00

Profit After Tax

144.90

126.60

142.60

151.60

119.70

108.20

114.50

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

144.90

126.60

142.60

151.60

119.70

108.20

114.50

Share in Profit of Associates

0.00

Minority Interest

57.00

48.10

42.80

45.00

43.30

38.90

32.40

Other related items

0.00

Consolidated Net Profit

201.90

174.70

185.40

196.60

163.00

147.10

146.90

Equity Capital

0.00

Face Value

0.01

Reserves

2,438.20

2,373.80

2,280.10

2,159.10

2,067.00

1,959.80

1,839.40

Earnings per share (EPS)

1.43

1.24

1.39

1.48

1.18

1.06

1.12

Diluted Earnings per share

1.43

1.24

1.39

1.48

1.18

1.06

1.12

Operating Profit Margin (Excl OI)

18.35%

16.49%

17.77%

18.35%

16.53%

15.48%

16.57%

Gross Profit Margin

22.28%

20.46%

21.73%

21.84%

19.89%

19.41%

19.9%

PAT Margin

9.38%

8.57%

9.78%

10.42%

8.52%

8.01%

8.8%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.54% vs 1.36% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 15.57% vs -5.77% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 13.44% vs -3.83% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -1.95% vs 1.32% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Encompass Health Corp. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

1,544.60

1,569.49

-24.89

-1.59%

Other Operating Income

0.00

Total Operating income

1,544.60

1,569.49

-24.89

-1.59%

Raw Material Cost

1,192.80

1,667.13

-474.33

-28.45%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

801.10

0.00

801.10

Power Cost

0.00

Manufacturing Expenses

30.20

1.72

28.48

1,655.81%

Selling and Distribution Expenses

68.40

58.76

9.64

16.41%

Other Expenses

-83.13

-0.17

-82.96

-48,800.00%

Total Expenditure (Excl Depreciation)

1,261.20

1,725.89

-464.69

-26.92%

Operating Profit (PBDIT) excl Other Income

283.40

-156.40

439.80

281.20%

Other Income

4.50

7.98

-3.48

-43.61%

Operating Profit (PBDIT)

374.30

-141.45

515.75

364.62%

Interest

30.20

1.72

28.48

1,655.81%

Exceptional Items

0.00

-37.42

37.42

100.00%

Gross Profit (PBDT)

351.80

-97.64

449.44

460.30%

Depreciation

86.40

6.97

79.43

1,139.60%

Profit Before Tax

257.70

-187.56

445.26

237.40%

Tax

55.40

1.32

54.08

4,096.97%

Provisions and contingencies

0.00

Profit After Tax

144.90

-188.88

333.78

176.72%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

144.90

-188.88

333.78

176.72%

Share in Profit of Associates

0.00

Minority Interest

57.00

0.00

57.00

Other related items

0.00

Consolidated Net Profit

201.90

-188.88

390.78

206.89%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

2,438.20

126.73

2,311.47

1,823.93%

Earnings per share (EPS)

1.43

-0.46

1.89

410.87%

Diluted Earnings per share

1.43

-0.46

1.89

410.87%

Operating Profit Margin (Excl OI)

18.35%

-9.97%

0.00

28.32%

Gross Profit Margin

22.28%

-11.51%

0.00

33.79%

PAT Margin

9.38%

-12.03%

0.00

21.41%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 154.46 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 4.54% vs 1.36% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 9.94% vs 12.69% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 20.19 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 15.57% vs -5.77% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 23.87% vs 27.74% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 36.98 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 13.44% vs -3.83% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 19.17% vs 19.35% in Dec 2024

Quarterly - Interest

Interest 3.02 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -1.95% vs 1.32% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -8.48% vs -5.44% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.35%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024